デフォルト表紙
市場調査レポート
商品コード
1619121

人工網膜の市場規模、シェア、成長分析、製品タイプ別、用途別、地域別-産業別予測-2024~2031年

Artificial Retina Market Size, Share, Growth Analysis, By Product Type (Epiretinal Implants, Subretinal Implants), By Application (Age-Related Macular Degeneration (AMD), Retinitis Pigmentosa), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
人工網膜の市場規模、シェア、成長分析、製品タイプ別、用途別、地域別-産業別予測-2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工網膜の世界市場規模は2022年に52億米ドルと評価され、2023年の64億8,000万米ドルから2031年には376億4,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは24.6%で成長する展望です。

世界の人工網膜市場は、医療技術の進歩と網膜疾患の罹患率の上昇により、著しい成長が見込まれています。人工網膜(網膜プロテーゼ)は、網膜色素変性症や加齢黄斑変性症などを患う人々の視力回復を目的とした革新的なデバイスです。効果的な治療に対するこの需要の急増は、ワイヤレス通信や電極設計の改良など、これらのシステムの機能性を高める技術革新によって後押しされています。研究開発への投資、政府のイニシアティブ、有利な償還制度が市場拡大をさらに後押ししています。北米は産業大手と先端技術の導入に支えられて市場を独占しているが、アジア太平洋は医療投資の増加と網膜の健康問題に対する意識の高まりにより、大きな成長を遂げようとしています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の展望
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主要市場の考察

  • 重要成功要因
  • 競合の程度
  • 主要投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • ケーススタディ

人工網膜市場規模:製品タイプ別&CAGR(2024~2031年)

  • 市場概要
  • 網膜上インプラント
  • 網膜下インプラント
  • その他

人工網膜市場規模:用途別&CAGR(2024~2031年)

  • 市場概要
  • 加齢黄斑変性症(AMD)
  • 網膜色素変性症

人工網膜市場規模&CAGR(2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較(2021~2023年)

主要企業プロファイル

  • Pixium Vision
  • Axorus
  • Intelligent Medical Implants
  • LambdaVision, Inc.
  • Nidek Co. Ltd.
  • Nano Retina
  • Bionic Vision Technologies
  • Optobionics
  • Medtronic
  • Vivani Medical Inc.
  • Labtician Ophthalmics, Inc.
  • Retina Implant AG
  • Altris, Inc.
  • Second Sight Medical Applications, Inc.
  • Neurotech Pharmaceuticals
  • iBIONICS
  • RenovaCare, Inc.
  • Okuvision GmbH
  • VisionCare, Inc.

結論と推奨事項

目次
Product Code: SQMIG35B2100

Global Artificial Retina Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.48 billion in 2023 to USD 37.64 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global Artificial Retina Market is poised for remarkable growth due to advancements in medical technology and the rising incidence of retinal diseases. Artificial retinas, or retinal prostheses, are innovative devices aimed at restoring vision for those suffering from conditions like retinitis pigmentosa and age-related macular degeneration. This surge in demand for effective treatments is bolstered by technological innovations, including wireless communication and improved electrode designs, enhancing the functionality of these systems. Investments in R&D, government initiatives, and favorable reimbursement frameworks further drive market expansion. North America dominates the market, underpinned by major industry players and adoption of advanced technologies, while the Asia-Pacific region is set for significant growth due to increasing healthcare investments and awareness of retinal health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Retina market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Retina Market Segmental Analysis

Global Artificial Retina Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Epiretinal Implants, Subretinal Implants, and Others. Based on Application, the market is segmented into Age-Related Macular Degeneration (AMD), and Retinitis Pigmentosa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Retina Market

A significant factor propelling the Global Artificial Retina Market is the rising incidence of retinal diseases. Conditions like retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy are becoming more common, driving demand for innovative artificial retina technologies. As the global population ages and the prevalence of chronic illnesses escalates, there is an increasing need for effective solutions to restore vision for those affected by retinal diseases. This urgent demand for advanced treatment options contributes to the overall growth and expansion of the artificial retina market, highlighting the critical role it plays in addressing these challenging health issues.

Restraints in the Global Artificial Retina Market

One significant limitation in the Global Artificial Retina market is the prohibitive cost associated with both the devices and the related procedures. The intricate and advanced technology involved in creating artificial retina systems, along with the substantial expenses tied to research, development, manufacturing, and obtaining regulatory approvals, leads to elevated pricing of these implants. This issue of affordability and accessibility hampers widespread adoption, particularly in areas where healthcare resources are scarce or where income levels are lower. As a result, the high costs present a considerable obstacle to market expansion, especially in developing regions and for patients facing financial constraints.

Market Trends of the Global Artificial Retina Market

The Global Artificial Retina Market is witnessing a significant trend towards miniaturization and integration of wireless communication technologies. As advancements in materials and engineering techniques progress, manufacturers are focusing on developing more compact, lightweight artificial retina devices that promise easier implantation and greater patient comfort. This movement is complemented by an emphasis on incorporating wireless features, enabling seamless data transfer and efficient remote monitoring, which paves the way for potential system upgrades and enhancements in functionality. This trend not only aims to enhance the user experience but also seeks to advance the clinical capabilities and overall effectiveness of artificial retina systems, driving innovation in the field.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Artificial Retina Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Epiretinal Implants
  • Subretinal Implants
  • Others

Global Artificial Retina Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Age-Related Macular Degeneration (AMD)
  • Retinitis Pigmentosa

Global Artificial Retina Market Size & CAGR (2024-2031)

  • North America, (Product Type, Application)
    • US
    • Canada
  • Europe, (Product Type, Application)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product Type, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product Type, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product Type, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Pixium Vision
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Axorus
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intelligent Medical Implants
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LambdaVision, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nidek Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nano Retina
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionic Vision Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optobionics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vivani Medical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labtician Ophthalmics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Retina Implant AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altris, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Second Sight Medical Applications, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurotech Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iBIONICS
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RenovaCare, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Okuvision GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VisionCare, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation